Published Online
on May 14, 2007

A more recent version of this article appeared on July 1, 2007

This Article Full Text (PDF) All Versions of this Article: 50/1/82    most recent HYPERTENSIONAHA.107.088955v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nietlispach, F. Articles by Brunner-La Rocca, H. P. Search for Related Content PubMed PubMed Citation Articles by Nietlispach, F. Articles by Brunner-La Rocca, H. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FLUDROCORTISONE NITRIC OXIDE Related Collections Pathophysiology Endothelium/vascular type/nitric oxide Related Article

Submitted on February 9, 2007
Revised on March 4, 2007

Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men

Fabian Nietlispach; Barbara Julius; Ruth Schindler; Alain Bernheim; Christoph Binkert; Wolfgang Kiowski; and Hans Peter Brunner-La Rocca^*

From the Clinic of Cardiology, Department of Internal Medicine (F.N., R.S., A.B., H.P.B.-L.R.), University Hospital Basel, Switzerland; the Division of Cardiology, Department of Internal Medicine (B.J.), Kantonsspital Aarau, Switzerland; Actelion Pharmaceuticals (C.B.), Allschwil, Switzerland; and HerzGefässZentrum Klinik Im Park Zürich (W.K.), Switzerland.

^* To whom correspondence should be addressed. E-mail: hbrunner{at}uhbs.ch.

Abstract--Aldosterone has rapid nongenomic effects in the human vasculature. However, data are not uniform and little is known about chronic effects of aldosterone. Therefore, we investigated acute and chronic effects of elevated aldosterone levels on endothelial function in the forearm vasculature of healthy men. In a first crossover study, the effects of arterial aldosterone infusion in ascending doses (3.3 to 55 pmol/min per 1000 mL forearm volume) on forearm blood flow were investigated in 8 healthy men (26±2 years). In a second study, endothelium-dependent (acetylcholine; 0.08, 0.275, and 2.75 µmol/min per 1000 mL) and endothelium-independent (sodium nitroprusside 0.02 µmol/min per 1000 mL) vasodilation and basal nitric oxide formation (forearm blood flow response to blockade by N^G-monomethyl-L-arginine 8 µmol/min per 1000 mL) were tested in 10 healthy men (age 30±5 years) at baseline, during infusion of 55 pmol/1000 mL per min aldosterone (acute effects), and after 0.3 mg/d oral fludrocortisone for 2 weeks (chronic effects) on separate days. Forearm blood flow was assessed by venous occlusion plethysmography. No change in forearm blood flow was seen with aldosterone infusion alone. Acute coinfusion of aldosterone increased vasodilation to sodium nitroprusside by 93% (P<0.01) and to acetylcholine by 60% (P=0.14). Response to N^G-monomethyl-L-arginine did not change. After 2 weeks of oral fludrocortisone, response to acetylcholine was enhanced by 72% compared with baseline (P=0.03). Additionally, response to N^G-monomethyl-L-arginine was enhanced by 80% compared with baseline (P=0.05). Aldosterone acutely enhances vasodilation to exogenous nitric oxide whereas mineralocorticoid excess for 2 weeks enhances basal nitric oxide bioactivity and improves endothelium dependent, nitric oxide-mediated vasodilation in the forearm vasculature of healthy men.

Key words: aldosterone • endothelial function • mineralocorticoid excess • forearm vasculature • nitric oxide

Related Article:

Aldosterone: Villain or Protector?

Gail K. Adler and Gordon H. Williams
Hypertension 2007 50: 31-32. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				G. L. Pierce, S. D. Beske, B. R. Lawson, K. L. Southall, F. J. Benay, A. J. Donato, and D. R. Seals Weight Loss Alone Improves Conduit and Resistance Artery Endothelial Function in Young and Older Overweight/Obese Adults Hypertension, July 1, 2008; 52(1): 72 - 79. [Abstract] [Full Text] [PDF]

				C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction Hypertension, November 1, 2007; 50(5): 919 - 925. [Abstract] [Full Text] [PDF]

				G. K. Adler and G. H. Williams Aldosterone: Villain or Protector? Hypertension, July 1, 2007; 50(1): 31 - 32. [Full Text] [PDF]